UMC Utrecht account plan
Leading academic healthcare provider
At a glance
UMC Utrecht is a Dutch university medical centre for complex care, research and education, with an average 9,745 FTEs in 2025.
UMC Utrecht is one of the Dutch university medical centres, a public-law entity combining academic patient care (including the Wilhelmina Children's Hospital), research, education with Utrecht University and valorisation through UMC Utrecht Holding B.V. Patients come to it for complex, often rare care, financed mainly through contracts with health insurers such as Zilveren Kruis, externally funded research and its outpatient pharmacy. In FY2025 consolidated operating income was 1.759,00 (in € millions, Dutch notation; 2024: 1.684,60) and the net result was €38.3 million, €8.5 million above budget. It employed an average 9,745 FTEs, more than 12,000 colleagues. It sits on the Utrecht Science Park and works in the EWUU alliance with Eindhoven University of Technology, Wageningen University & Research and Utrecht University.
Business units
Patient care (clinical divisions)
Divisions including Brain, Heart and Lung, Image and Oncology, Surgical Specialties, Vital Functions, Women & Baby and Pediatrics run complex care under management contracts with the Executive Board. Admissions and outpatient treatments rose versus 2024, patients rated care 8.7, and regional networks agreed on concentrating eighteen complex cancer and vascular treatments.
Wilhelmina Children's Hospital (WKZ)
Part of the Pediatrics division, providing care from pregnancy to young adulthood, and described as the largest children's muscle centre in the Netherlands. Its renovation has been under way since November 2024.
Research
1,300 FTE funded through other sources; fundraising capacity 183 million euros in 2025Six strategic programs (Circulatory Health, Brain, Infection & Immunity, Cancer, Child Health, Regenerative Medicine) with seven accelerators. Fundraising capacity of 183 million euros compares with a benchmark of 112 million, and UMC Utrecht coordinates EuroHeartPath with 27 million euros from Horizon Europe.
Education (Faculty of Medical Sciences)
Run with Utrecht University under the education strategy The New Utrecht School, with a revised Medicine curriculum starting in September 2027. In 2025 it co-founded the University Public Health Training Institute with Amsterdam UMC.
Valorisation (UMC Utrecht Holding B.V.)
A 100% owned holding for patents, licensing, stakes in spin-offs and care-related innovation services; spin-off TigaTx received ARPA-H and US National Cancer Institute grants for its IgA antibody TIGA-001.
Strategic priorities
- Organisational transformation
- A new matrix structure designed bottom-up under the Connecting Worlds strategy: L2 leaders placed in 2025, L3-L5 to follow in 2026, and support functions such as finance and procurement centralised into services from 1 January 2026.
- EBITDA target for 2029
- An EBITDA of €110 million in 2029, backed by an additional cost-saving program, to absorb rising capital costs from renovation and new construction and expected cuts to the academic component.
- New ERP system
- Tender, selection and award completed in 2025 to replace an outdated, heavily customised ERP landscape; phased implementation in 2026 and go-live targeted for January 1, 2027.
- Data and AI in care
- A central data platform, the Autoscriber transcription pilot to be rolled out across outpatient clinics in 2026, no-show prediction on the national HealthSage AI platform and AI-supported discharge documentation in NICU and ICU.
- Care at home and in networks
- Continuous monitoring with wearable sensors restarting in 2026, the HOME-ART study treating respiratory infections at home, digital transmural referral with national roll-out in 2026, and network care under the Integrated Care Agreement.
- Sustainability
- Commitment to the Green Deal Sustainable Healthcare 3.0, more than 50% of waste recycled with a target of at most 25% residual waste, and reprocessing of heart catheters.
Investments and deals
- Wilhelmina Children's Hospital renovation
- Renovation under way since November 2024 under the Integrated Strategic Real Estate Plan, with heat pumps planned for 2026 and approved projects for the WKZ outpatient clinic, Reproductive Medicine and the Pharmacy; financed from own resources through 2027, with external financing such as loans needed for later phases.
- ERP replacement
- New ERP awarded in 2025, implemented in phases in 2026, go-live targeted for January 1, 2027 and optimisation in 2027.
- Cybersecurity and NIS2
- NEN 7510 compliance and a NIS2 taskforce aiming for full NIS2 compliance in 2026.
- Research grants and consortia
- National Growth Fund projects such as RegMedXB and OncodePact, new grants awarded in 2025 (CPBT, DRIVE-RM, IMAGINE), and the AtheroNeth consortium with 6 million from the Dutch Heart Foundation.
Challenges and risks
- Stacked strategic programmes
- The Supervisory Board flags that the transformation, ERP, housing and efficiency programmes running at once put high pressure on the organisation.
- Labour market and sick leave
- Labour shortages persist; 2,247 new colleagues were hired from 1,172 vacancies in 2025 and sick leave stayed at 5.7%, still above norm.
- Pressure on care spending
- National growth limits under the Integrated Care Agreement, government cuts to the academic component and inflation weigh on income, while rising care demand and complexity increase costs.
- Rising personnel and capital costs
- Salaries, social charges and pension costs rose to 988,9 (€ millions) in 2025 on collective labour agreement developments, and renovation and new construction raise capital costs.
What leadership says
“must transform”
Where a supplier can help
- ERP implementation support
- The phased 2026 ERP implementation and January 1, 2027 go-live create demand for implementation, data migration, testing and change-management partners, especially with finance and procurement newly centralised.
- Clinical AI and documentation tools
- Rolling out AI transcription to outpatient clinics and AI-supported discharge documentation fits suppliers of clinical AI, speech recognition and integration with the HiX electronic patient record.
- Cost-saving and efficiency programmes
- The €110 million EBITDA target for 2029 and its cost-saving program open room for procurement, capacity management and operational efficiency services.
- NIS2 cybersecurity
- The NIS2 taskforce's goal of full compliance in 2026 points to security assessment, monitoring and compliance providers.
- Construction and sustainable building
- The Wilhelmina Children's Hospital renovation, heat pumps and Green Deal commitments fit construction, energy and medical device reprocessing suppliers.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like UMC Utrecht?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Annual Report UMC Utrecht 2025
- UMC Utrecht is one of the Dutch university medical centres: a public-law legal entity combining academic patient care (including the Wilhelmina Children's Hospital), research, education (Faculty of Medical Sciences with Utrecht University) and valorisation (UMC Utrecht Holding B.V., 100% owned).
- FY2025 (consolidated, € millions): operating income 1.759,00 (2024: 1.684,60); salaries, social charges and pension costs 988,9; net result 38,3 (2024: 30,6), €8.5 million above budget; group equity 570,1; total assets 1.274,3; capital ratio 44,74%; liquidity 1,76.
- Workforce: an average 9,745 FTEs in 2025 (more than 12,000 colleagues): 8,445 FTE in collectively funded care, education and research and 1,300 FTE in research funded through other sources; 2,247 new colleagues hired; sick leave stable at 5.7%, still above norm.
- Research is organised in six strategic programs (Circulatory Health, Brain, Infection & Immunity, Cancer, Child Health, Regenerative Medicine) with seven 'accelerators'; fundraising capacity for research reached 183 million euros (benchmark 112 million).
- Strategy "Connecting Worlds" plus an organisational transformation: a new matrix structure designed bottom-up; L2 leaders placed as quartermasters in 2025, L3-L5 to follow in 2026; support functions (finance, procurement) centralised into services from 1 January 2026.
- Financial target: an EBITDA of €110 million in 2029, backed by an additional cost-saving program, to absorb rising capital costs from renovation and new construction and expected cuts to the academic component.
- ERP replacement: tender, selection and award completed in 2025; phased implementation in 2026, go-live targeted for January 1, 2027.
- Real estate: Wilhelmina Children's Hospital renovation under way since November 2024; current plans financed from own resources through 2027, external financing (e.g. loans) needed for later phases.
- Digital/AI: central data platform, AI moved "from pilot to practice" (Autoscriber transcription pilot to be rolled out in outpatient clinics in 2026, no-show prediction on the national HealthSage AI platform), NIS2 taskforce for compliance by 2026.
- Leadership: chair Carina Hilders left on 24 February 2026; Louis Bont (dean and vice-chair since 1 December 2025) is acting chair with Josefien Kursten (finance, real estate, digitalisation) and Remco van Lunteren (operations); Supervisory Board chaired by Henk Broeders.
Questions about UMC Utrecht
What is UMC Utrecht?
UMC Utrecht is a Dutch university medical centre combining complex patient care, including the Wilhelmina Children's Hospital, with research, education with Utrecht University and valorisation of inventions.
How many people work at UMC Utrecht?
UMC Utrecht employed an average 9,745 FTEs in 2025, more than 12,000 colleagues, of whom 1,300 FTE worked in research funded through other sources.
What are UMC Utrecht's priorities?
For 2026 the Supervisory Board names the organisational transformation, the new ERP system, the housing plans and structural efficiency, with an EBITDA target of €110 million in 2029.
Who leads UMC Utrecht?
After chair Carina Hilders left on 24 February 2026, dean and vice-chair Louis Bont is acting chair of the Executive Board with Josefien Kursten and Remco van Lunteren. The Supervisory Board is chaired by Henk Broeders.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)